UBS upgrades Genting Singapore (G13.SG) to Buy from Neutral, noting the counter has underperformed the weighted performance of the 5 listed Macau operators by around 25% and the STI by around 7.0% YTD.
“We think Genting Singapore is turning into a bona-fide China (wealth creation) play, with strong growth in VIP from North Asia (especially China) expected to continue into 2011-2012E.”
It tips VIP volumes of US$18 billion ($22.8 billion)-US$20 billion per quarter at RWS in 2011 (putting RWS in the same league as the top-performing Macau properties). It expects HK/China to account for as much as 50% of RWS' total gross gaming revenue by 2012, when its VIP-targeted expansion will be rolled out.
Overall, the house says China VIP growth, capacity expansion in 2012, a net cash position and potential for new projects together make Genting an attractive stock at this valuation. It lowers its target to $2.30 from $2.39, based on 15X 2011E EV/EBITDA (vs 16X previously).
Subscribe to:
Post Comments (Atom)
Blog Archive
-
▼
2011
(72)
-
▼
April
(12)
- CityDev BUY Target Price $14.31 by CLSA
- Axiata BUY Target Price RM5.83 by OSK Research
- Cosco BUY Target Price $3.00 by Citigroup
- Golden Agri BUY Target Price $0.88 by OCBC Research
- Keppel Land BUY Target Price $5.09 by OCBC Research
- Axiata BUY Target Price RM5.75 by RHB Research
- MAS SELL Target Price RM1.60 by OSK Research
- YTL Power BUY Target Price RM2.57 by RHB Research
- Tenaga SELL Target Price RM5.73 by Maybank Investm...
- Mudajaya BUY Target Price RM7.44 by OSK Research
- Genting Singapore BUY Target Price $2.30 by UBS
- Biosensors BUY Target Price $1.36 by OCBC IR
-
▼
April
(12)
No comments:
Post a Comment